サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1747820

ケロイド治療の世界市場

Keloid Treatment

出版日
ページ情報
英文 280 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.42円
ケロイド治療の世界市場
出版日: 2025年06月13日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 280 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ケロイド治療の世界市場は2030年までに41億米ドルに達する

2024年に36億米ドルと推定されるケロイド治療の世界市場は、2024年から2030年にかけてCAGR 2.2%で成長し、2030年には41億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである閉塞性ドレッシングは、CAGR 2.3％を記録し、分析期間終了時には19億米ドルに達すると予測されます。圧迫療法分野の成長率は、分析期間中CAGR 1.5％と推定されます。

米国市場は9億8,060万米ドルと推定、中国はCAGR4.1％で成長予測

米国のケロイド治療市場は、2024年に9億8,060万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに7億6,750万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは4.1%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ0.9%と1.8%と予測されています。欧州では、ドイツがCAGR 1.3%で成長すると予測されています。

世界のケロイド治療市場- 主要動向と促進要因のまとめ

ケロイド治療が皮膚科および美容医療で注目される理由とは？

ケロイドは、皮膚損傷部位に発生する異常な線維性過形成であり、しばしば元の創傷縁を越えて進展し、最初の外傷が治癒した後も長期間持続します。ケロイドは良性であるが、盛り上がり、変色し、時には痛みを伴うため、身体的に不快であり、心理的苦痛を伴うことがあります。ケロイドに対する治療的・美容的解決策に対する需要の高まりは、特に皮膚の健康と美容皮膚科学に対する認識が多様な人々の間で拡大するにつれて、世界の治療市場の成長を後押ししています。

これらの病変は、特にアフリカ系、アジア系、ラテンアメリカ系の人々において、遺伝的素因が重要な役割を果たす皮膚の色の濃い人々に不釣り合いに影響を及ぼします。世界の医療制度が民族皮膚科学をより積極的に取り入れるようになるにつれ、的を絞ったエビデンスに基づいたケロイド治療の必要性が高まっています。ケロイドは再発率が高く、治療に対する反応も様々であるため、ケロイドの管理には通常、多方面からのアプローチが必要です。そのため、効果的で侵襲が少なく、効果が持続する治療法に対する需要が、皮膚科診療における臨床研究と技術革新の両方を促進しています。

ケロイド治療における主要な治療法とその進歩は？

ケロイドの治療には、従来の治療法から新しい技術まで、様々なアプローチがあります。第一選択の治療法としては、コルチコステロイド注射がよく行われ、炎症とコラーゲン合成を抑え、時間の経過とともに瘢痕を平らにし、柔らかくするのに役立ちます。5-フルオロウラシル（5-FU）やブレオマイシンと併用することで、より高い効果が期待できます。凍結療法は、液体窒素を用いてケロイド組織を凍結させ、体積を減少させるもので、病変が小さい場合や腔内療法と併用されることが多いです。

レーザー治療、特にパルス色素レーザー（PDL）とフラクショナルCO2レーザーは、コラーゲンのリモデリングを刺激しながらケロイドの質感、色、不快感を改善する治療法として人気を集めています。外科的切除は必要な場合もあるが、放射線療法、圧迫療法、シリコンジェルシートなどの補助療法を併用しない限り、再発のリスクが高いです。最近の動向としては、創傷端の機械的緊張を緩和するためのボツリヌス毒素注射の使用や、線維増殖過程の根底にあるものに対処することを目的とした幹細胞を用いた治療や遺伝子改変治療の適用があります。このような技術革新は、症状の抑制にとどまらず、長期的な管理・予防へとケロイド治療を広げています。

ケロイド治療の市場需要を牽引している患者グループと臨床現場とは？

ケロイド治療を求める患者は、痒み、灼熱感、運動制限などの身体的症状や、心理的苦痛、美容的関心など、医療と美容の両領域にまたがっています。若年層、特に20～40歳代の患者は、美容的処置やパーソナルケアへの関与が高いため、需要の主要な牽引役となっています。ピアス、火傷、にきびからの回復を含む術後・外傷後の患者は、もう一つの重要なユーザー層です。

皮膚科医、形成外科医、腫瘍外科医、美容医療開業医は、ケロイド管理を臨床に取り入れるようになってきています。遠隔皮膚科やデジタル診察プラットフォームの台頭は、特にこれまで専門的な皮膚治療が制限されていた恵まれない地域において、専門家による治療をより身近なものにしています。メディカル・スパ、外来診療所、美容外科センターも、レーザー治療と注射剤を組み合わせた低侵襲の治療パッケージを提供し、包括的な結果を得ることで、市場拡大に貢献しています。非外科的でダウンタイムの少ない治療への患者の嗜好のシフトが、世界的にケロイド治療の提供モデルを形成しています。

ケロイド治療市場の成長はいくつかの要因によって牽引されている...

ケロイド治療市場の成長は、肥厚性瘢痕疾患の有病率の上昇、皮膚の健康に対する意識の高まり、美容皮膚科の技術進歩など、いくつかの要因によって牽引されています。高齢化が進み、手術や美容整形が増えるにつれて、術後や外傷に関連したケロイドの発生率が上昇し、効果的な治療プロトコルの必要性が高まっています。また、レーザーベースのプラットフォーム、生物学的製剤、併用療法の普及は、臨床結果と患者の満足度を向上させ、採用をさらに後押ししています。

新興国を中心に拡大する美容皮膚科分野は、ケロイドに特化したソリューションを提供する既存ブランドと新規参入企業の双方に新たな機会をもたらしています。また、新製剤の規制承認、外用剤のデリバリーシステムの強化、AIや画像ツールによる個別化治療計画の役割の増大も、市場の勢いに寄与しています。さらに、ケロイド治療が総合的な傷跡管理や美容修復サービスに統合されることで、ヘルスケアや美容の分野全体にその魅力が広がっています。肌状態の改善に対する需要が拡大し続ける中、ケロイド治療市場は持続的なイノベーションと商業的拡大が期待できる位置にあります。

セグメント

治療（包帯療法、圧迫療法、凍結手術、切除術、その他の治療）、最終用途（病院、皮膚科クリニック、外来手術センター、その他の最終用途）

調査対象企業の例（合計 34注目）

  • Avita Medical Limited
  • Bausch Health Companies Inc.
  • Bristol-Myers Squibb Company
  • CellResearch Corporation
  • Cynosure
  • Enaltus LLC
  • GlaxoSmithKline plc
  • Hoffmann-La Roche Ltd.
  • Kissei Pharmaceutical Co., Ltd.
  • Lumenis
  • Merck & Co., Inc.
  • Mylan N.V.（now part of Viatris）
  • Novartis AG
  • Pacific World Corporation
  • Perrigo Company plc
  • Pfizer Inc.
  • Revitol Corporation
  • RXi Pharmaceuticals, Inc.
  • Sensus Healthcare
  • Sonoma Pharmaceuticals, Inc.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・業界団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストを含む1万4,949人のエコノミストを追跡しています。我々の16,491以上のレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP35266

Global Keloid Treatment Market to Reach US$4.1 Billion by 2030

The global market for Keloid Treatment estimated at US$3.6 Billion in the year 2024, is expected to reach US$4.1 Billion by 2030, growing at a CAGR of 2.2% over the analysis period 2024-2030. Occlusive Dressing, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$1.9 Billion by the end of the analysis period. Growth in the Compression Therapy segment is estimated at 1.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$980.6 Million While China is Forecast to Grow at 4.1% CAGR

The Keloid Treatment market in the U.S. is estimated at US$980.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$767.5 Million by the year 2030 trailing a CAGR of 4.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 1.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.3% CAGR.

Global Keloid Treatment Market - Key Trends & Drivers Summarized

Why Is Keloid Treatment Becoming a Priority in Dermatological and Aesthetic Medicine?

Keloids are abnormal, fibrous overgrowths that occur at the site of skin injuries, often extending beyond the original wound margin and persisting long after the initial trauma has healed. While they are benign, keloids can be physically uncomfortable and psychologically distressing due to their raised, discolored, and sometimes painful nature. The increasing demand for both therapeutic and aesthetic solutions for keloids is propelling growth in the global treatment market, especially as awareness of skin health and cosmetic dermatology expands across diverse populations.

These lesions disproportionately affect individuals with darker skin types, particularly in populations of African, Asian, and Latin American descent, where genetic predisposition plays a significant role. As global health systems become more inclusive of ethnic dermatology, the need for targeted, evidence-based keloid treatments is rising. Keloid management typically requires a multimodal approach, as the condition has a high recurrence rate and variable response to therapy. The demand for effective, minimally invasive, and long-lasting treatments is therefore driving both clinical research and innovation in dermatological practices.

What Are the Leading Modalities in Keloid Management and How Are They Evolving?

The treatment of keloids involves a variety of approaches, ranging from conventional therapies to emerging technologies. First-line treatments often include corticosteroid injections, which reduce inflammation and collagen synthesis, helping to flatten and soften the scar over time. These may be combined with 5-fluorouracil (5-FU) or bleomycin to enhance efficacy. Cryotherapy, which uses liquid nitrogen to freeze and reduce the volume of keloid tissue, is frequently employed for smaller lesions or in conjunction with intralesional therapy.

Laser therapy-particularly pulsed dye lasers (PDL) and fractional CO2 lasers-is gaining popularity for improving keloid texture, color, and discomfort while stimulating collagen remodeling. Surgical excision, while sometimes necessary, carries a high risk of recurrence unless paired with adjunct therapies like radiation, pressure therapy, or silicone gel sheeting. More recent developments include the use of botulinum toxin injections to reduce mechanical tension at wound edges and the application of stem cell-based or gene-modifying treatments aimed at addressing the underlying fibroproliferative processes. These innovations are expanding the keloid treatment landscape beyond symptom suppression toward long-term management and prevention.

Which Patient Groups and Clinical Practices Are Driving Market Demand for Keloid Solutions?

Patients seeking keloid treatment span both medical and cosmetic domains, with individuals motivated by physical symptoms such as itching, burning, or restricted movement, as well as psychological distress and cosmetic concerns. Younger patients, particularly in the 20-40 age group, are key drivers of demand due to higher engagement with aesthetic procedures and personal care. Post-surgical and post-trauma patients, including those recovering from piercings, burns, and acne, represent another significant user base.

Dermatologists, plastic surgeons, oncologic surgeons, and aesthetic medicine practitioners are increasingly incorporating keloid management into their clinical offerings. The rise of teledermatology and digital consultation platforms is making expert care more accessible, especially in underserved regions where specialist skin care was previously limited. Medical spas, outpatient clinics, and cosmetic surgery centers are also contributing to market expansion by offering minimally invasive treatment packages, often combining laser therapy and injectables for comprehensive results. The shift in patient preference toward non-surgical, low-downtime interventions is shaping the delivery model of keloid care globally.

The Growth in the Keloid Treatment Market Is Driven by Several Factors…

The growth in the keloid treatment market is driven by several factors including the rising prevalence of hypertrophic scarring disorders, increasing awareness of skin health, and technological advancements in aesthetic dermatology. As populations age and undergo more surgeries and aesthetic procedures, the incidence of post-operative and trauma-related keloids is rising, fueling the need for effective treatment protocols. The proliferation of laser-based platforms, biologics, and combination therapies is also improving clinical outcomes and patient satisfaction, further encouraging adoption.

The expanding cosmetic dermatology sector-particularly in emerging economies-is creating new opportunities for both established brands and novel entrants offering keloid-specific solutions. Regulatory approvals of new drug formulations, enhanced delivery systems for topical agents, and the growing role of personalized treatment planning through AI and imaging tools are also contributing to market momentum. Furthermore, the integration of keloid treatment into comprehensive scar management and aesthetic restoration services is broadening its appeal across healthcare and beauty disciplines. As demand for skin condition correction continues to grow, the keloid treatment market is positioned for sustained innovation and commercial expansion.

SCOPE OF STUDY:

The report analyzes the Keloid Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment (Occlusive Dressing, Compression Therapy, Cryosurgery, Excision, Other Treatments); End-Use (Hospitals, Dermatology Clinics, Ambulatory Surgery Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Avita Medical Limited
  • Bausch Health Companies Inc.
  • Bristol-Myers Squibb Company
  • CellResearch Corporation
  • Cynosure
  • Enaltus LLC
  • GlaxoSmithKline plc
  • Hoffmann-La Roche Ltd.
  • Kissei Pharmaceutical Co., Ltd.
  • Lumenis
  • Merck & Co., Inc.
  • Mylan N.V. (now part of Viatris)
  • Novartis AG
  • Pacific World Corporation
  • Perrigo Company plc
  • Pfizer Inc.
  • Revitol Corporation
  • RXi Pharmaceuticals, Inc.
  • Sensus Healthcare
  • Sonoma Pharmaceuticals, Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Keloid Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Keloid and Hypertrophic Scars Due to Surgical Procedures, Burns, and Skin Injuries Propels Demand for Targeted Treatments
    • Growing Awareness of Aesthetic and Psychological Impacts of Keloid Scars Strengthens Demand for Medical and Cosmetic Interventions
    • Advancements in Combination Therapies (e.g., corticosteroids with laser or cryotherapy) Improve Efficacy and Expand Adoption of Keloid Treatment Protocols
    • Increasing Use of Non-Invasive Treatment Options Drives Popularity of Silicone Gel Sheets, Pressure Therapy, and Topical Formulations
    • Emergence of Laser-Based Therapies (e.g., PDL, CO? lasers) Enhances Treatment Precision and Reduces Recurrence Rates in Resistant Keloids
    • Rising Demand for Personalized Dermatological Treatments Encourages Use of Tailored Regimens Based on Scar Type and Skin Sensitivity
    • Growing Number of Dermatology Clinics and Cosmetic Surgery Centers Expands Access to Advanced Keloid Removal Options
    • Ongoing Research Into Molecular Mechanisms of Fibrosis Fuels Development of Novel Antifibrotic Agents and Biologics
    • Increased Availability of OTC Keloid Treatment Products Encourages Early Intervention and Self-Care Among Consumers
    • Surge in Cosmetic Surgery and Body Piercing Trends Among Youth Contributes to Rising Incidence and Demand for Preventive Treatments
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Keloid Treatment Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Keloid Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Keloid Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Keloid Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Occlusive Dressing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Occlusive Dressing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Occlusive Dressing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Compression Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Compression Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Compression Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cryosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Cryosurgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Cryosurgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Excision by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Excision by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Excision by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Treatments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Treatments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Dermatology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Dermatology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Dermatology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Keloid Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Keloid Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Keloid Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Keloid Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Keloid Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Keloid Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Keloid Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Keloid Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Keloid Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Keloid Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Keloid Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Keloid Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Keloid Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Keloid Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Keloid Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Keloid Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Keloid Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Keloid Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Keloid Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Keloid Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Argentina 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Brazil 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Mexico 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Keloid Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Keloid Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Keloid Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Keloid Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Iran 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Israel 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: UAE 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Keloid Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Keloid Treatment by Treatment - Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Keloid Treatment by Treatment - Percentage Breakdown of Value Sales for Occlusive Dressing, Compression Therapy, Cryosurgery, Excision and Other Treatments for the Years 2015, 2025 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Keloid Treatment by End-Use - Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Africa 15-Year Perspective for Keloid Treatment by End-Use - Percentage Breakdown of Value Sales for Hospitals, Dermatology Clinics, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION